Association of pre-miR-146a rs2910164 polymorphism with the risk of head and neck cancer

Anticancer Research

Volumn 33, Issue 1, 2013, Pages 341-346

  Orsós, Zsuzsa ^a   Szanyi, István ^b   Csejtei, András ^c   Gerlinger, Imre ^b   Ember, István ^a   Kiss, István ^a  

^a Departments of Public Health   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Markusovszky Teaching Hospital   (Hungary)

Author keywords

Head and neck; MiR 146a; Polymorphism; Squamous cell carcinoma

Indexed keywords

MICRORNA 146A; PRE MICRORNA 146A; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA PRECURSORS;

EID: 84873048134     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J and Whelan S: Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18: 4779-4786, 1998.
3. Joseph AW and D'Souza G: Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 45: 739-764, 2012.
4. O'Driscoll L: The emerging world of microRNAs. Anticancer Res 26: 4271-4278, 2006.
5. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
6. Doench JG and Sharp PA: Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511, 2004.
7. Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-97, 2004.
9. Esquela-Kerscher A and Slack FJ: Oncomirs -microRNAs with a role in cancer. Nat Rev Can 6: 259-269, 2006.
10. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
11. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
12. Labbaye C and Testa U: The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer J Hematol Oncol 27: 13. 2012.
13. Taganov KD, Boldin MP, Chang KJ and Baltimore D: NF-κBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486, 2006.
14. Rusca N and Monticelli S: miR-146a in immunity and disease. Mol Biol Int 2011: 437301, 2011.
15. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR and de la Chapelle A: Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105: 7269-74, 2008.
16. Lin SL, Chiang A, Chang D and Ying SY: Loss of miR-146a function in hormone-refractory prostate cancer. RNA 14: 417-24, 2008.
17. Papaconstantinou IG, Lykoudis PM, Gazouli M, Manta A, Polymeneas G and Voros D: A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas 41: 671-677, 2012.
18. Kogo R, Mimori K, Tanaka F, Komune S and Mori M: Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 17: 4277-4284, 2011.
19. Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ and Lin SC: Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol 48: 404-408, 2012.
20. Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, Wegrzyn J, Kuchenbauer F, Hirst M, Tohyama K, Humphries RK, Lam WL, Marra M and Karsan A: Genome-wide identification of human microRNAs located in leukemiaassociated genomic alterations. Blood 13: 595-607, 2011.
21. Lavon I, Zrihan D, Granit A, Einstein O, Fainstein N, Cohen MA, Cohen MA, Zelikovitch B, Shoshan Y, Spektor S, Reubinoff BE, Felig Y, Gerlitz O, Ben-Hur T, Smith Y and Siegal T: Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol 12: 422-433, 2010.
22. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM and de la Chapelle A: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005.
23. Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF: A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 70: 467-472, 2010.
24. Zhou B, Wang K, Wang Y, Xi M, Zhang Z, Song Y and Zhang L: Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog 50: 499-505, 2011.
25. Yue C, Wang M, Ding B, Wang W, Fu S, Zhou D, Zhang Z and Han S: Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol Oncol 122: 33-37, 2011.
26. Zhou F, Zhu H, Luo D, Wang M, Dong X, Hong Y, Lu B, Zhou Y, Zhou J, Zhang Z and Gong W: A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol 31: 1290-1295, 2012.
27. Lian H, Wang L and Zhang J: Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS One 7: e31615, 2012.
28. Mittal RD, Gangwar R, George GP, Mittal T and Kapoor R: Investigative role of pre-microRNAs in bladder cancer patients: A case control study in North India. DNA Cell Biol 30: 401-406, 2011.
29. Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O and Sandikci M: No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: A case control study. Gene 486: 104-109, 2011.
30. Xiang Y, Fan S, Cao J, Huang S and Zhang LP: Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39: 7019-7023, 2012.
31. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM and Wei Q: Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116: 4753-4760, 2010.
32. UNESCO-UIS/OECD/EUROSTAT: UOE Data Collection on Education Systems (Volume 1) 2012. Available from: http:// www.uis.unesco.org/Library/Documents/ uoe-data-collectioneducation-systems-v1-en.pdf. Last accessed: 18 October 2012.
33. Blin N and Stafford DW: A general method for isolation of high molecular weight DNA from eucaryotes. Nucleic Acids Res 3: 2303-2308, 1976.
34. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T and Tajima K: Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91: 865-868, 2000.
35. Hishida A, Matsuo K, Goto Y, Naito M, Wakai Y, Tajima K and Hamajima N: Combined effect of miR-146a rs2910164 G/C polymorphism and toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci 56: 1131-1137, 2011.
36. Lourenco GJ, Silva EF, Rinck-Junior JA, Chone CT and Lima CS: CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma. Tumour Biol 32: 1209-1215, 2011.
37. Gresner P, Gromadzinska J, Polanska K, Twardowska E, Jurewicz J and Wasowicz W: Genetic variability of XRCC3 and RAD51 modulates the risk of head and neck cancer. Gene 504: 166-174, 2012.
38. Feng J, Li L, Zhao YS, Tang SQ, Yang HB and Liu SX: Interaction between CYP 2C19.*3 polymorphism and smoking in relation to laryngeal carcinoma in the Chinese Han population. Genet Mol Res 10: 3331-3337, 2011.
39. Hirsch FR, Varella-Garcia M and Cappuzzo F: Predictive value of EGFR and HER2 overexpression in advanced non-small cell lung cancer. Oncogene 28(Suppl): S32-37, 2009.
40. Howe LR and Brown PH: Targeting the HER/EGFR/ERBB family to prevent breast cancer. Cancer Prev Res 4: 1149-1157, 2011.
41. DiDonato JA, Mercurio F and Karin M: NF-κB and the link between inflammation and cancer. Immunol Rev 246: 379-400, 2012.
42. Miyazono K, Ehata S and Koinuma D: Tumor-promoting functions of transforming growth factor-β in progression of cancer. Ups J Med Sci 117: 143-152, 2012.
43. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C and Zheng ZM: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.